IPO round-up: K2M lists on Nasdaq; skin Dx firm aims for $25m IPO; Siemens to spin out audiology unit
This article was originally published in Clinica
Executive Summary
Spinal device company K2M has moved ahead with its initial public offering on the Nasdaq, joining the growing wave of medtech floats this year. The Leesburg, Virgina-based firm saw its stock open at $15 per share on 8 May – over 5.4 million shares were traded through the day, dipping to a low of $14.51 and hitting a high of $15.23, before settling back and closing at $15. The pricing is a tad lower than what the company had anticipated. At the end of April, K2M had said in a SEC filing that it planned to sell 8.8 million shares at $16-18 each. K2M, listed under the ticker symbol KTWO, develops complex and minimally invasive technologies to treat difficult and challenging spinal pathologies.